Literature DB >> 16995847

Immunosuppressive therapy protocols in kidney transplantation in adults.

Jasenko Karamehić1, Marc Lorber, Richard Formica, Faris Gavrankapetanović, Bećir Heljić, Demo Subasić, Lamija Zecević.   

Abstract

In practical terms, regardless of HLA compatibility level, whenever tissues are transplanted from one person to another it is essential to suppress the immune response of the recipient. A variety of methods are available however, the most frequently used ones have the disadvantage of being immunologicaly non specific. The consequence is a difficult balance between immunosuppression sufficient to prevent the tissue rejection and maintenance of immune system at the level of ability to adequately deal with an infection. The goal, not yet achieved, is to find a way of generating donor specific immunosuppression that leaves the immune machinery otherwise completely intact. The major approaches to immunosuppression are described below.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16995847      PMCID: PMC7193658          DOI: 10.17305/bjbms.2006.3143

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  10 in total

1.  Analytical approaches for transplant research, 2004.

Authors:  Douglas E Schaubel; Dawn M Dykstra; Susan Murray; Valarie B Ashby; Keith P McCullough; David M Dickinson; Tempie E Hulbert-Shearon; Randall L Webb; Robert A Wolfe
Journal:  Am J Transplant       Date:  2005-04       Impact factor: 8.086

2.  Transplant data: sources, collection and research considerations, 2004.

Authors:  David M Dickinson; Dawn M Dykstra; Gregory N Levine; Shiqian Li; James C Welch; Randall L Webb
Journal:  Am J Transplant       Date:  2005-04       Impact factor: 8.086

3.  Immunosuppression: evolution in practice and trends, 1993-2003.

Authors:  Ron Shapiro; James B Young; Edgar L Milford; James F Trotter; Rami T Bustami; Alan B Leichtman
Journal:  Am J Transplant       Date:  2005-04       Impact factor: 8.086

4.  A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts.

Authors:  A S MacDonald
Journal:  Transplantation       Date:  2001-01-27       Impact factor: 4.939

5.  Alemtuzumab induction and prednisone-free maintenance immunotherapy in simultaneous pancreas-kidney transplantation comparison with rabbit antithymocyte globulin induction - long-term results.

Authors:  D B Kaufman; J R Leventhal; L G Gallon; M A Parker
Journal:  Am J Transplant       Date:  2006-02       Impact factor: 8.086

6.  Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group.

Authors:  B D Kahan
Journal:  Lancet       Date:  2000-07-15       Impact factor: 79.321

7.  FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.

Authors:  Helio Tedesco-Silva; Georges Mourad; Barry D Kahan; Josep Grinyo Boira; Willem Weimar; Shamkant Mulgaonkar; Björn Nashan; Soren Madsen; Bernard Charpentier; Pascale Pellet; Yves Vanrenterghem
Journal:  Transplantation       Date:  2005-06-15       Impact factor: 4.939

8.  Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil.

Authors:  Flavio Vincenti; Anthony Monaco; Joseph Grinyo; Milan Kinkhabwala; Allan Roza
Journal:  Am J Transplant       Date:  2003-03       Impact factor: 8.086

9.  Prospective, randomized, multi-center trial of antibody induction therapy in simultaneous pancreas-kidney transplantation.

Authors:  Dixon B Kaufman; George W Burke; David S Bruce; Christopher P Johnson; A Osama Gaber; David E R Sutherland; Robert M Merion; Scott A Gruber; Eugene Schweitzer; John P Leone; Christopher L Marsh; Edward Alfrey; Waldo Concepcion; Mark D Stegall; James A Schulak; Paul F Gores; Enrico Benedetti; Craig Smith; Alice K Henning; Fernando Kuehnel; Sarah King; William E Fitzsimmons
Journal:  Am J Transplant       Date:  2003-07       Impact factor: 8.086

10.  A comparison of discharge immunosuppressive drug regimens in primary cadaveric kidney transplantation.

Authors:  Wida S Cherikh; H Myron Kauffman; Jude Maghirang; Anthony J Bleyer; Christopher P Johnson
Journal:  Transplantation       Date:  2003-08-15       Impact factor: 4.939

  10 in total
  1 in total

1.  The relationship between human leukocyte antigens (HLA) and renal cell carcinoma.

Authors:  Erkan Yilmaz; Arman Çekmen; Emre Akkuş; Bülent Önal; Ali Uğur Özalp; Vural Solok; Ergun Erdoğan; Bülent Eren
Journal:  Bosn J Basic Med Sci       Date:  2010-11       Impact factor: 3.363

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.